Drugstore chain operator CVS Corp. said Thursday it has completed its $26.5 billion acquisition of pharmacy benefits manager Caremark Rx Inc.
The combined company will be named CVS/Caremark Corp. and will trade on the New York Stock Exchange under the ticker "CVS." Caremark shares will no longer trade under the ticker "CMX" on the NYSE.
As a term of CVS' offer, the combined company will begin buying back about 150 million shares of its common stock, or about 10 percent of shares outstanding, for $35 per share in the next five business days.
The combined company's board consists of 7 members from each..
.
